Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs

2002 ◽  
Vol 13 (4) ◽  
pp. 211-229 ◽  
Author(s):  
J. D. Griffies ◽  
C. L. Mendelsohn ◽  
W. S. Rosenkrantz ◽  
R. Muse ◽  
M. J. Boord ◽  
...  
Keyword(s):  
Lupus Erythematosus ◽  
Discoid Lupus Erythematosus ◽  
Pemphigus Erythematosus

Topical 0.1% Tacrolimus for the Treatment of Discoid Lupus Erythematosus and Pemphigus Erythematosus in Dogs

2004 ◽  
Vol 40 (1) ◽  
pp. 29-41 ◽  
Author(s):  
Joel D. Griffies ◽  
Colleen L. Mendelsohn ◽  
Wayne S. Rosenkrantz ◽  
Rusty Muse ◽  
Mona J. Boord ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Topical Application ◽  
Lupus Erythematosus ◽  
Adjunctive Treatment ◽  
Discoid Lupus Erythematosus ◽  
Laboratory Parameters ◽  
Pemphigus Erythematosus

Topical 0.1% tacrolimus was used for treatment of localized lesions associated with 10 cases of discoid lupus erythematosus (DLE) and two cases of pemphigus erythematosus (PE) either as a sole therapy (n=2) or as an adjunctive treatment (n=10). Eight of 10 dogs with DLE and both dogs with PE were improved following 8 weeks of topical application. In six of the eight dogs that improved, other medications were discontinued. No adverse effects in clinical or laboratory parameters were noted throughout the study.

Systemic scleroderma with discoid lupus erythematosus.

1991 ◽  
Vol 53 (1) ◽  
pp. 11-14
Author(s):  
Hideki ONO ◽  
Tetsuo SASAKI ◽  
Hiroshi NAKAJIMA ◽  
Hitoshi KOMATSU ◽  
Yasuhiko KATO
Keyword(s):  
Lupus Erythematosus ◽  
Systemic Scleroderma ◽  
Discoid Lupus Erythematosus

A Case of Squamous Cell Carcinoma Arising from Discoid Lupus Erythematosus on the Sole

2008 ◽  
Vol 70 (1) ◽  
pp. 23-26
Author(s):  
Yoko YOKOYAMA ◽  
Fumihide OGAWA ◽  
Kazuhiro KOMURA ◽  
Emiko TAKEISHI ◽  
Shinichi SATO
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Lupus Erythematosus ◽  
Discoid Lupus Erythematosus
Sign in / Sign up

Export Citation Format

Share Document